Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antimicrobial Stewardship in the Sub-Saharan African Region
    Release Date:
    Partner: International Society for Infectious Diseases
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology All
    Enhancing Patient-Centered Outcomes in Emergency Department Migraine Management
    Release Date:
    Partner: American College of Emergency Physicians (ACEP)
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Biosimilars in Hematologic Malignancies & Supportive Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Advances in Atopic Dermatitis for Advanced Practitioners
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2020 RD US- Next Generation PET Imaging for ATTR-CM
    Release Date:
    Partner: GE Healthcare
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment
    Release Date:
    Partner: Mayo Clinic/Global Bridges
    Review Process: Expert Review Panel
    Education Internal Medicine China, Malaysia, Taiwan, Thailand
    4th Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Partner: Bristol-Myers Squibb
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    2021 Rheumatology Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA